The stock of Cardlytics Inc (NASDAQ: CDLX) has decreased by -6.87 when compared to last closing price of 12.37. Despite this, the company has experienced a -5.42% fall in its stock price over the last five trading sessions. The Motley Fool reported 2024-04-02 that Cardlytics stock skyrocketed because its business showed improved trends. The company then refinanced some of its debt at a higher rate, which troubled investors.
Is It Worth Investing in Cardlytics Inc (NASDAQ: CDLX) Right Now?
Company’s 36-month beta value is 1.50.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for CDLX is 41.10M, and currently, short sellers hold a 14.48% ratio of that floaft. The average trading volume of CDLX on April 25, 2024 was 1.78M shares.
CDLX’s Market Performance
CDLX stock saw a decrease of -5.42% in the past week, with a monthly decline of -43.11% and a quarterly a decrease of 90.10%. The volatility ratio for the week is 6.64%, and the volatility levels for the last 30 days are 8.96% for Cardlytics Inc (CDLX). The simple moving average for the last 20 days is -13.81% for CDLX stock, with a simple moving average of 5.95% for the last 200 days.
Analysts’ Opinion of CDLX
Many brokerage firms have already submitted their reports for CDLX stocks, with Craig Hallum repeating the rating for CDLX by listing it as a “Buy.” The predicted price for CDLX in the upcoming period, according to Craig Hallum is $18 based on the research report published on March 15, 2024 of the current year 2024.
Lake Street, on the other hand, stated in their research note that they expect to see CDLX reach a price target of $13. The rating they have provided for CDLX stocks is “Buy” according to the report published on November 29th, 2023.
Wells Fargo gave a rating of “Underweight” to CDLX, setting the target price at $13 in the report published on September 08th of the previous year.
CDLX Trading at 5.37% from the 50-Day Moving Average
After a stumble in the market that brought CDLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.86% of loss for the given period.
Volatility was left at 8.96%, however, over the last 30 days, the volatility rate increased by 6.64%, as shares sank -15.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +71.94% upper at present.
During the last 5 trading sessions, CDLX fell by -5.42%, which changed the moving average for the period of 200-days by +72.97% in comparison to the 20-day moving average, which settled at $13.26. In addition, Cardlytics Inc saw 25.08% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDLX starting from Gupta Amit, who sale 23,416 shares at the price of $11.91 back on Apr 24 ’24. After this action, Gupta Amit now owns 122,676 shares of Cardlytics Inc, valued at $278,885 using the latest closing price.
Lynton Nicholas Hollmeyer, the Chief Legal & Privacy Officer of Cardlytics Inc, sale 276 shares at $12.76 during a trade that took place back on Apr 23 ’24, which means that Lynton Nicholas Hollmeyer is holding 71,761 shares at $3,521 based on the most recent closing price.
Stock Fundamentals for CDLX
Current profitability levels for the company are sitting at:
- -0.28 for the present operating margin
- 0.43 for the gross margin
The net margin for Cardlytics Inc stands at -0.37. The total capital return value is set at -0.22. Equity return is now at value -77.77, with -21.29 for asset returns.
Based on Cardlytics Inc (CDLX), the company’s capital structure generated 0.66 points at debt to capital in total, while cash flow to debt ratio is standing at -0.0. The debt to equity ratio resting at 1.93. The interest coverage ratio of the stock is -14.32.
Currently, EBITDA for the company is -34.15 million with net debt to EBITDA at -4.0. When we switch over and look at the enterprise to sales, we see a ratio of 2.18. The receivables turnover for the company is 2.48for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.31.
Conclusion
In a nutshell, Cardlytics Inc (CDLX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
